Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.

Kim, Ji-Won; Kim, Eun Jin; Kwon, Hyun Hee; Jung, Chi Young; Kim, Kyung Chan; Choe, Jung-Yoon; Hong, Hyo-Lim

Kim, Ji-Won; Kim, Eun Jin; Kwon, Hyun Hee; Jung, Chi Young; Kim, Kyung Chan; Choe, Jung-Yoon; Hong, Hyo-Lim.

Afiliação

Kim JW; Divisions of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Kim EJ; Divisions of Pulmonology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Kwon HH; Divisions of Infectious Diseases, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Jung CY; Divisions of Pulmonology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Kim KC; Divisions of Pulmonology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Choe JY; Divisions of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Hong HL; Divisions of Infectious Diseases, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.

Korean J Intern Med ; 36(Suppl 1): S253-S263, 2021 03.

Article em En | MEDLINE | ID: mdl-32536150

Assuntos

Antivirais/uso terapêutico; Tratamento Farmacológico da COVID-19; Hidroxicloroquina/uso terapêutico; Lopinavir/uso terapêutico; Ritonavir/uso terapêutico; SARS-CoV-2/efeitos dos fármacos; Idoso; Idoso de 80 Anos ou mais; Antivirais/efeitos adversos; COVID-19/diagnóstico; COVID-19/virologia; Combinação de Medicamentos; Feminino; Humanos; Hidroxicloroquina/efeitos adversos; Lopinavir/efeitos adversos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos; Ritonavir/efeitos adversos; SARS-CoV-2/patogenicidade; Fatores de Tempo; Resultado do Tratamento; Carga Viral

Palavras-chave

COVID-19; Hydroxychloroquine; Lopinavir-ritonavir; Severe acute respiratory syndrome coronavirus 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ritonavir / Lopinavir / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google